SFM
CPRX

Systematic Financial Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Systematic Financial Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5M Buy
747,515
+24,273
+3% +$578K 0.42% 94
2025
Q4 		$16.9M Buy
723,242
+37,578
+5% +$837K 0.4% 100
2025
Q3 		$13.5M Buy
685,664
+491,034
+252% +$10.1M 0.33% 120
2025
Q2 		$4.22M Buy
194,630
+13,240
+7% +$313K 0.11% 158
2025
Q1 		$4.4M Buy
+181,390
New +$4.08M 0.13% 153
2020
Q3 		– Sell
-67,665
Closed -$313K – 294
2020
Q2 		$313K Buy
+67,665
New +$304K 0.02% 333

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Systematic Financial Management's CPRX Position: Q1 2026 in Review

Systematic Financial Management increased its Catalyst Pharmaceutical (CPRX) stake by 3.4% in Q1 2026, buying an estimated $578K and bringing the position to 747,515 shares worth $18.5M. The position accounts for 0.42% of the portfolio, ranked #94.

Systematic Financial Management first reported a position in CPRX in Q2 2020 and has held it in 6 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Systematic Financial Management held 747,515 shares of Catalyst Pharmaceutical worth $18.5M as of Q1 2026.
  • Systematic Financial Management bought 24,273 Catalyst Pharmaceutical shares in Q1 2026, an estimated $578K.
  • Catalyst Pharmaceutical made up 0.42% of Systematic Financial Management's portfolio in Q1 2026, its #94 holding.
  • Systematic Financial Management first reported a position in Catalyst Pharmaceutical in Q2 2020 and has held it in 6 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Systematic Financial Management's 13F filing for Q1 2026, filed 13 May 2026.